Alfons Navarro

12PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersCancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 17, 2025
Diagnostic and Prognostic Value of hsa_piR_022710, hsa_piR_019822, and hsa_piR_020840 in Early-Stage Non-Small-Cell Lung Cancer: Implications for Recurrence and Survival in Squamous Cell Carcinoma Patients.

Yangyi He, Antonio Altuna-Coy, Melissa Acosta-Plasencia

|Jul 09, 2022
Characterization of the MicroRNA Cargo of Extracellular Vesicles Isolated from a Pulmonary Tumor-Draining Vein Identifies miR-203a-3p as a Relapse Biomarker for Resected Non-Small Cell Lung Cancer.

Bing Han, Laureano Molins, Yangyi He

|Feb 25, 2022
Screening for Prognostic microRNAs Associated with Treatment Failure in Diffuse Large B Cell Lymphoma.

Leyre Bento, Oliver Vögler, Adriana Sas-Barbeito

|Jan 27, 2022
Human embryonic mesenchymal lung-conditioned medium promotes differentiation to myofibroblast and loss of stemness phenotype in lung adenocarcinoma cell lines.

Jordi Canals, Alfons Navarro, Cristina Vila

|Jun 02, 2021
Deciphering miRNA-Target Relationships to Understand miRNA-Mediated Carcinogenesis.

Alfons Navarro

|Jun 02, 2021
Lincp21-RNA as Predictive Response Marker for Preoperative Chemoradiotherapy in Rectal Cancer.

Jose Carlos Benitez, Marc Campayo, Tania Díaz

Pageof 2

Frequent Collaborators

3 joint publications

Daniel Martinez

3 joint publications

Jorge Moises

3 joint publications

Laureano Molins

2 joint publications

Melissa Acosta-Plasencia